Atlas Trials

Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer

Clinical trial NCT00525642 · UNKNOWN

Trial details

NCT number
NCT00525642
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Breast NeoplasmsAdjuvantChemotherapy
Start date
2003-06-01
Enrollment
603

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.